US not fully safe with vaccinations unless Covid variants curbed: USAID

The United States is not assured of being fully safe from the coronavirus even with its high rate in vaccination unless it extends the global fight to defeat the variants from the scourge

Topics
Coronavirus Vaccine | Coronavirus | United States

ANI 

The is not assured of being fully safe from the even with its high rate in vaccination unless it extends the global fight to defeat the variants from the scourge, US Agency for International Development (USAID) COVID-19 Task Force Jeremy Konyndyk said Monday.

"We recognize that no matter how many people we vaccinated at home, the will not be fully safe as long as the virus rages on around the rest of the world and continues to replicate and generate new and potentially more dangerous," Konyndyk, who is assisting the Biden administration's global response to the pandemic, said.

Konyndyk cited India as an example of the work that needed to be done in subduing mutations of the virus, with President Joe Biden pledging to Indian Prime Minister Narendra Modi last week a range of emergency assistance, including oxygen-related supplies, vaccine materials and therapeutics.

"[The] variants (and) current surge in South Asia really underscore the devastating consequences and risks of continued global transmission and the urgency of accelerating efforts to end the pandemic," Konyndyk said.

In a speech to Congress last month, Biden said the would become "an arsenal of vaccines" for other countries once vaccination targets for Americans were met. Biden said the United States would make 20 million additional vaccines available for other countries by the end of June from its reserves of Pfizer, Moderna and Johnson & Johnson shots.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

Read our full coverage on Coronavirus Vaccine
First Published: Tue, May 25 2021. 07:07 IST
RECOMMENDED FOR YOU